Why Avenue Therapeutics (ATXI) Stock Is Falling Sharply
Why Avenue Therapeutics (ATXI) Stock Is Falling Sharply
Avenue Therapeutics (NASDAQ:ATXI) shares are trading lower by 20.7% to $4.92 during Monday's session after the company announced the exercise of warrants for $4.4 million in gross proceeds.
Avenue Therapeutics（納斯達克股票代碼：ATXI）在週一的交易中股價下跌20.7％，至4.92美元，此前該公司宣佈行使認股權證，總收益爲440萬美元。
These warrants were issued at different times with various exercise prices, but the warrant holders have agreed to exercise them at a reduced price of $6.20 per share. The company expects to receive approximately $4.4 million in gross proceeds from this exercise.
這些認股權證是在不同的時間發行的，行使價格各不相同，但認股權證持有人同意以每股6.20美元的較低價格行使這些認股權證。該公司預計將從此次活動中獲得約440萬美元的總收益。
In return for exercising the warrants, Avenue will issue new unregistered Series C and Series D warrants to the warrant holders, each allowing them to purchase up to 689,680 shares of common stock at an exercise price of $6.20 per share.
作爲行使認股權證的回報，Avenue將向認股權證持有人發行新的未註冊的C系列和D系列認股權證，每份認股權證允許他們以每股6.20美元的行使價購買多達689,680股普通股。
The new Series C warrants will be exercisable immediately and valid for five years, while the Series D warrants will be exercisable immediately but valid for eighteen months. The transaction is expected to close around May 1, 2024, subject to standard closing conditions.
新的C系列認股權證可立即行使，有效期爲五年，而D系列認股權證可立即行使，但有效期爲十八個月。該交易預計將於2024年5月1日左右完成，但須遵守標準成交條件。
Should I Sell My ATXI Stock?
我應該賣出我的 ATXI 股票嗎？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在決定持有或出售股票時，投資者應考慮其時間範圍、未實現收益和總回報。
Shares of Avenue Therapeutics have decreased by 93.29% in the past year. An investor who bought shares of Avenue Therapeutics at the beginning of the year would take a loss of $7.05 per share if they sold it today. The stock has fallen 56.03% over the past month, meaning an investor who bought shares on Mar. 1 would see a capital loss of $6.95.
在過去的一年中，Avenue Therapeutics的股價下跌了93.29％。年初購買Avenue Therapeutics股票的投資者如果今天出售股票，則每股虧損7.05美元。該股在過去一個月中下跌了56.03％，這意味着在3月1日購買股票的投資者將遭受6.95美元的資本損失。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Avenue Therapeutics stock currently has an RSI of 27.91, indicating oversold conditions.
投資者也可以考慮市場動態。相對強弱指數可用於表明股票是超買還是超賣。Avenue Therapeutics股票目前的相對強弱指數爲27.91，這表明存在超賣情況。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
要訪問高級製圖和分析工具以及股票數據，請查看 Benzinga PRO。免費試用。
ATXI has a 52-week high of $93.75 and a 52-week low of $4.77.
ATXI的52周高點爲93.75美元，52周低點爲4.77美元。
譯文內容由第三人軟體翻譯。